Mediolanum International Funds LTD Neurocrine Biosciences Inc Transaction History
Mediolanum International Funds LTD
- $7.21 Trillion
- Q1 2025
A detailed history of Mediolanum International Funds LTD transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Mediolanum International Funds LTD holds 57,716 shares of NBIX stock, worth $7.24 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
57,716
Previous 56,344
2.44%
Holding current value
$7.24 Million
Previous $7.7 Billion
15.22%
% of portfolio
0.09%
Previous 0.1%
Shares
5 transactions
Others Institutions Holding NBIX
# of Institutions
649Shares Held
97.6MCall Options Held
749KPut Options Held
553K-
Black Rock Inc. New York, NY14.2MShares$1.78 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.94MShares$1.25 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.53MShares$694 Million0.37% of portfolio
-
State Street Corp Boston, MA4.86MShares$610 Million0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY2.67MShares$335 Million0.02% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $12B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...